Download the following Poster Presentation: A metastatic biology gene expression assay to predict the risk of distant metastases in patients with localised prostate cancer treated with primary radical treatment.
Conclusion:

• The Metastatic Assay predicts BF and DM in PCa patients treated with either radical surgery or EBRT.
• This assay may help to select patients at low risk of relapse, who may benefit from an active surveillance approach, and to identify those patients at high risk of metastatic disease for additional treatment aimed at preventing disease recurrence